DEPOSEIN—how meaningful was the benefit from intrathecal chemotherapy?

摘要

We appreciate the interest of Shivaprasad and colleagues in the DEPOSEIN trial.1 Our colleagues (i) address imbalances between study groups summarized in their Table 1 and (ii) challenge the clinical relevance of the differences in outcome between groups.